ArticleBMC primary care2025
Knowledge, attitude, and practice (KAP) of primary health physicians towards glucose self-monitoring in patients with type2 diabetes mellitus in Palestine.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Determinants of self-monitoring adherence in type 2 diabetes: bridging the gap in patient care.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 Diabetes Mellitus (T2DM) stands as a significant global health challenge for individuals and societies. In the context of Palestine, T2DM affects about 9.2% of the Palestinian population and contributes to a relatively high complication rate. Effectivemanagement strategies including glucose self- monitoring need to be optimized to improve patient outcomes and alleviate the strain on the healthcare system. One of the physicians' roles in T2DM management is explaining and guiding patients towards the integration of glucose self-monitoring into their personal diabetes management routine. This study investigates the knowledge, attitudes, and practices of primary health care physicians who care for (T2DM) patients in the West Bank regarding glucose self-monitoring.
methodsA cross-sectional study was conducted among physicians working in PHC centers. The study period was from January to March 2024. Data was collected through a self-administered questionnaire.
resultsFive hundred ten medical doctors were surveyed and 300 of them replied, giving a response rate of 58.8%. The median age of the respondents was 35.0 [30.0, 41.0] years. Of the respondents, 180 (60.0%) were males. The median duration of practice as a doctor was 9.0 [5.0, 15.0] years. Most, 252 (84.0%), were general practitioners, 38 (12.7%) family medicine specialists, and 10 (3.3%) other specialties. Female respondents and those who saw more patients reported better knowledge (p < 0.05). The majority believed that glucose self-monitoring can improve patient outcomes, knew values of glucose self-monitoring that corresponded to HbA1c control and the microvascular complications of diabetes, and realized the importance of glucose self-monitoring for patients. However, 40% of them are not confident or somewhat confident about interpreting data and adjusting treatment plans. Regarding the respondent's practices, 39.3% of the doctors stated that they would recommend glucose- self monitoring to newly diagnosed type 2 diabetes patients more than one time a day.
conclusionThere was a positive attitude toward glucose self-monitoring among the respondents in the primary healthcare clinics. Conversely, the clinicians' glucose self-monitoring practices were suboptimal. Future research should examine the knowledge, attitudes, and practices of physicians who provide patient care in the private sector.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.